LOS ANGELES, Calif.--(BUSINESS WIRE)--Abraxis BioScience, Inc. (NASDAQ:ABBI), an integrated, global biopharmaceutical company, today announced that Thomas Silberg, president of Abraxis Pharmaceutical Products, the company’s hospital-based business, will present a company overview at the Bear Stearns Healthcare Conference on Tuesday, September 11, 2007 at 8:30 a.m. ET at the Grand Hyatt in New York City.
